Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Online Surveys to Assess the Perception and Performance of Imaging and Associated Aspects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03494335
Recruitment Status : Recruiting
First Posted : April 11, 2018
Last Update Posted : April 11, 2018
Sponsor:
Information provided by (Responsible Party):
Michael V. Knopp MD, PhD, Ohio State University

Brief Summary:
In this exploratory study, we would like to investigate the background, perception, current use practices, potential unmet needs and/or challenges in regard to imaging procedures, imaging technology, or any other aspect related to the broader field of imaging.

Condition or disease Intervention/treatment Phase
Perception of Imaging Other: Online surveys Not Applicable

Detailed Description:
We plan to include volunteer participants to complete these surveys. The goal of these exploratory efforts will be to increase the currently very limited information available in the topics of interest stated above, and the findings, even if only from limited group of respondents, will help us guide our research development, prepare for design of clinical trials, guide special interest groups, and serve as role data for appropriate scientific publications.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 5000 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Online Surveys to Assess the Perception and Performance of Imaging Associated Aspects
Estimated Study Start Date : April 30, 2018
Estimated Primary Completion Date : April 30, 2020
Estimated Study Completion Date : April 30, 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Volunteer participants
Volunteer participants will participate in surveys assessing their perception of various imaging aspects.
Other: Online surveys
We are targeting health care providers for these surveys that are involved in or use imaging.




Primary Outcome Measures :
  1. Perception of PET/CT imaging agent Y-90 [ Time Frame: through study completion, on average 2-5 years ]
    Responses to online surveys assessing participants' perceptions of Y-90 will be analyzed

  2. Perception of PET/CT imaging agent NaF [ Time Frame: through study completion, on average 2-5 years ]
    Responses to online surveys assessing participants' perceptions of NaF will be analyzed

  3. Perception of MRI contrast agents [ Time Frame: through study completion, on average 2-5 years ]
    Responses to online surveys assessing participants' perceptions of MR contrast agents will be analyzed



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male and female participants who have access to the online survey tool and can read and write in English

Exclusion Criteria:

  • None, as this is voluntary

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03494335


Contacts
Layout table for location contacts
Contact: Melanie Hughes 614-293-9998 office@wcibmi.org
Contact: Michael V Knopp, MD, PhD 614-293-9998 knopp.16@osu.edu

Locations
Layout table for location information
United States, Ohio
Martha Morehouse Medical Plaza Recruiting
Columbus, Ohio, United States, 43221
Contact: Michael V Knopp, MD, PhD    614-293-9998    knopp.16@osu.edu   
Sub-Investigator: Chadwick L Wright, MD, PhD         
Sub-Investigator: Katherine M Binzel, PhD         
Sub-Investigator: Michelle I Knopp, PhD         
Sponsors and Collaborators
Ohio State University
Investigators
Layout table for investigator information
Principal Investigator: Michael V Knopp, MD, PhD Ohio State University
  Study Documents (Full-Text)

Documents provided by Michael V. Knopp MD, PhD, Ohio State University:
Study Protocol  [PDF] October 9, 2017

Layout table for additonal information
Responsible Party: Michael V. Knopp MD, PhD, Professor, Ohio State University
ClinicalTrials.gov Identifier: NCT03494335    
Other Study ID Numbers: RP0320_S02/2018E0141
First Posted: April 11, 2018    Key Record Dates
Last Update Posted: April 11, 2018
Last Verified: March 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No